PT-141 (Bremelanotide / Vyleesi) vs Testosterone (TRT)
Both are used for sexual health. Here's how they compare on human evidence, mechanism, safety and availability — in plain English.
| PT-141 (Bremelanotide / Vyleesi) | Testosterone (TRT) | |
|---|---|---|
| Human evidence | ★★★★☆ | ★★★★★ |
| Legal status | FDA Approved, Not Approved | Controlled, Prescription |
| How it works | α-MSH-derived peptide activating central melanocortin receptors MC3R/MC4R in brain desire/reward circuits — acting on libido centrally, unlike PDE-5 drugs (which act on blood flow). | Binds the cytoplasmic androgen receptor (AR); the hormone-receptor complex translocates to the nucleus and binds androgen response elements (AREs) on DNA, switching on genes for muscle protein synthesis, erythropoiesis, and bone density.… |
| In plain English | Works in the brain's desire centre rather than on plumbing — FDA-approved for low sexual desire in premenopausal women, used off-label by men. | Testosterone slots into a docking station (the androgen receptor) inside your cells, which then walks to the cell's DNA and switches on the "build muscle, make blood, strengthen bone" genes. TRT restores a normal level in men who are… |
| Bottom line | The only centrally-acting approved libido drug. | Transformative for confirmed low-T; a different risk equation for enhancement in normal men. |
| Availability | Not widely approved | Controlled substance |
Which is better for sexual health?
Testosterone (TRT) has the stronger human-evidence rating (★★★★★ vs ★★★★☆), but the right choice still depends on your goal, tolerance and budget.
Full breakdowns: PT-141 (Bremelanotide / Vyleesi) · Testosterone (TRT).
Common questions
Is PT-141 (Bremelanotide / Vyleesi) or Testosterone (TRT) better for sexual health?
Testosterone (TRT) has the stronger human-evidence rating (★★★★★ vs ★★★★☆), but the right choice still depends on your goal, tolerance and budget.
What's the difference between PT-141 (Bremelanotide / Vyleesi) and Testosterone (TRT)?
PT-141 (Bremelanotide / Vyleesi): The only centrally-acting approved libido drug. — Testosterone (TRT): Transformative for confirmed low-T; a different risk equation for enhancement in normal men.